Abstract
Objetivo
Conocer las diferencias entre el riesgo coronario de los sujetos con glucemia basal alterada (GBA), intolerancia oral a la glucosa (ITG) y diabetes mellitus tipo 2 según las clasificaciones diagnósticas de la OMS-85 y ADA-97 en una población adulta con un riesgo alto de presentar diabetes mellitus.
Diseño
Estudio descriptivo, transversal, multicéntrico.
Emplazamiento
Atención primaria, 7 centros de salud.
Pacientes
Un total de 970 sujetos considerados población de riesgo para diabetes mellitus tipo 2.
Mediciones
Se clasificaron los sujetos según los criterios OMS-85 (normales, ITG, diabetes) y según la ADA-97 (normales, GBA y diabetes). Se recogieron las siguientes variables: edad, sexo, consumo de tabaco, índice de masa corporal, tensión arterial sistólica, tensión arterial diastólica, glucemia basal, glucemia a las 2 horas de la PTOG, HbA1c, microalbuminuria, colesterol total, cHDL, cLDL, triglicéridos y se estimó el cálculo del riesgo coronario mediante la tabla de Wilson et al de 1998, basada en el estudio Framingham.
Resultados
Se evaluó a 970 sujetos con una edad media de 58,6 ± 12,4 años, 453 varones (46,7%) y 517 mujeres (53,3%). En el análisis de la presencia de factores de riesgo cardiovascular se observa que éstos son menos frecuentes en los sujetos normales y que su prevalencia es más elevada en los diabéticos (OMS y ADA). No existen diferencias significativas entre el riesgo coronario y los diversos factores de riesgo cuando se analizan grupos homónimos OMS–ADA (normales, ITG-GBA o diabéticos). Según la clasificación de la OMS-85, el riesgo coronario en los distintos tipos de alteraciones del metabolismo de la glucosa fue un 11,3% en sujetos normales, un 14% en ITG y un 27,3% en diabéticos, y según la ADA-97 un 11,4% en sujetos normales, un 15,7% en GBA y un 29,5% en diabéticos.
Conclusiones
A mayor grado de patología hidrocarbonada, mayor coexistencia de factores de riesgo y mayor estimación del riesgo coronario. No hay diferencias importantes entre los estadios de las clasificaciones OMS y ADA ni en la presencia de factores de riesgo cardiovascular ni en relación al riesgo coronario.
Palabras clave: Atención primaria, Diabetes, Riesgo cardiovascular
Abstract
Aim
To identify the differences between coronary heart disease risk in patients with altered basal glucemia (ABG), oral glucose intolerance (OGI) and type II diabetes mellitus according to the WHO-85 and ADA-97 diagnostic classifications, in an adult population at high risk for diabetes mellitus.
Design
Descriptive, cross-sectional, multicenter study.
Setting
Seven primary health care centers in Spain.
Patient
970 persons considered the population at risk for type II diabetes mellitus.
Measures
Participants were classified according to the criteria of the WHO-85 (normal, OGI, diabetes) and the ADA-97 system (normal, ABG, diabetes). The following variables were recorded: age, sex, smoking habit, body mass index, systolic blood pressure, diastolic blood pressure, basal glucemia, glucemia 2 h after an oral glucose tolerance test, HbA1c, microalbmuniuria, total cholesterol, HDL, LDL and triglycerides. Coronary heart disease risk was calculated with the 1998 table developed by Wilson et al. on the basis of the Framingham study.
Results
A total of 970 participants were studied. Mean age was 58.6 #+ 12.4 years; 453 were men (46.7%) and 517 were women (53.3%). Our analysis showed that cardiovascular disease risk factors were less frequent in normal subjects, and that their prevalence was higher in persons with diabetes (according to both WHO and ADA classifications). There were no significant differences in coronary heart disease risk or different risk factors between analogous groups in the two classification systems (normal, OGI/ABG or diabetes). Coronary heart disease risk in persons with different types of alterations in glucose metabolism was 11.3% in normal subjects, 14% in persons with OGI and 27.3% in persons with diabetes according to the WHO-85 system, and 11.4% in normal subjects, 15.7% in persons with ABG and 29.5% in persons with diabetes according to the ADA-97 system.
Conclusions
The greater the alteration in carbohydrate metabolism, the greater the coexistence of risk factors and the estimated risk of coronary heart disease. There were no significant differences in the presence of cardiovascular risk factors, or in the relationship between carbohydrate metabolism and coronary heart disease risk, between analogous stages identified with one classification system or the other.
Key words: Primary care, Diabetes, Cardiovascular disease, Risk
Bibliografía
- 1.World Health Organization . Diabetes Mellitus Report of a WHO Study Group. World Health Organization; Geneva: 1985. informe técnico 727. [PubMed] [Google Scholar]
- 2.Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., Keen H. Coronary–heart disease risk and impaired glucose tolerance: The Whitehall Study. Lancet. 1980:1373–1376. doi: 10.1016/s0140-6736(80)92651-3. [DOI] [PubMed] [Google Scholar]
- 3.Wingard D.L., Scheidt-Nave C., Barret-Connor E.L., Mc Philips J.B. Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. Diabetes Care. 1993;16:1022–1025. doi: 10.2337/diacare.16.7.1022. [DOI] [PubMed] [Google Scholar]
- 4.Expert Workshop on Impaired Glucose Tolerance Diabet Med. 1996;13(Suppl 2):1–31. [PubMed] [Google Scholar]
- 5.Gerstein H.C., Yusuf S. Dysglycaemia and risk of cardiovascular disease. Lancet. 1996;347:949–950. doi: 10.1016/s0140-6736(96)91420-8. [DOI] [PubMed] [Google Scholar]
- 6.Kelin R. Hyperglucemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18:258–264. doi: 10.2337/diacare.18.2.258. [DOI] [PubMed] [Google Scholar]
- 7.The Expert Committee on the Diagnosis. Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care. 1997;20(Suppl 1):1183–1197. doi: 10.2337/diacare.20.7.1183. [DOI] [PubMed] [Google Scholar]
- 8.Harris M.I., Eastman R.C., Cowie C.C., Flegal K.M., Eberhardt M.S. Comparison of diabetes diagnostic categories in the US population according to 1997 American Diabetes Association and 1980–1985 World Health Organisation diagnostic criteria. Diabetes Care. 1997;20:1859–1862. doi: 10.2337/diacare.20.12.1859. [DOI] [PubMed] [Google Scholar]
- 9.Shaw J.E., De Courten M.P., Hodge A.M. IGT or IFG for predicting NIDDM. Who is right, WHO or ADA? Diabetes. 1998;47(Suppl 1):150. [Google Scholar]
- 10.Wahl P.W., Savage P.J., Patsy B.M., Orchard T.J., Robbins J.A., Tracy R.P. Diabetes in older adults: comparison of the 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet. 1998;352:1012–1015. doi: 10.1016/S0140-6736(98)04055-0. [DOI] [PubMed] [Google Scholar]
- 11.Costa B., Franch J., Martín F., Morató J., Donado A., Basora J., IGT Research Group Impact of the American Diabetes Association diagnosis criteria on high-risk Spanish population. Diab Res Clin Pract. 1999;46:75–81. doi: 10.1016/s0168-8227(99)00066-2. [DOI] [PubMed] [Google Scholar]
- 12.Martín L., Costa B., Donado A., Basora T., Basora J., Piñol J.L. Los criterios de la ADA infravaloran el impacto de la diabetes en la población española de más alto riesgo. Aten Primaria. 2000;26:517–524. doi: 10.1016/S0212-6567(00)78716-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.The DECODE Study Group on Behalf of the European Diabetes Epidemiology Group Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia. 1999;42:647–654. doi: 10.1007/s001250051211. [DOI] [PubMed] [Google Scholar]
- 14.Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., Sekikawa A. The Funagata Diabetes Study. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. Diabetes Care. 1999;22:920–924. doi: 10.2337/diacare.22.6.920. [DOI] [PubMed] [Google Scholar]
- 15.Vegt F., Dekker J., Stehouwer C., Nijpels G., Bouter L., Heine R. Similar 9-year mortality risks and reproducibility for the WHO and ADA glucose Tolerance Categories: the Hoorn Study. Diabetes Care. 2000;23:40–44. doi: 10.2337/diacare.23.1.40. [DOI] [PubMed] [Google Scholar]
- 16.Reaven G.M. Role of insulin resistance in human disease. Diabetes. 1988;37:1597–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
- 17.Grundy S.M., Chair PhD. Benjamin M.D., Burke G., Chait A., Eckel R. Diabetes and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. AHA Scientific Statement. Circulation. 1999;100:1134–1146. doi: 10.1161/01.cir.100.10.1134. [DOI] [PubMed] [Google Scholar]
- 18.Donahue R.P., Orchard T.J. Diabetes mellitus and macrovascular complications. An epidemiological perspective. Diabetes Care. 1992;15:1141–1155. doi: 10.2337/diacare.15.9.1141. [DOI] [PubMed] [Google Scholar]
- 19.Goldberg R.B. Cardiovascular disease in diabetic patients. Med Clin North Am. 2000;84:81–93. doi: 10.1016/s0025-7125(05)70208-x. [DOI] [PubMed] [Google Scholar]
- 20.Geiss L.S., Herman W.H., Smith P.J. Mortality in non-insulin dependent diabetes. In: Harris M.I., Cowie C.C., Stern M.P., editors. Diabetes in America. 2nd ed. National Institutes of Health; Bethesda: 1995. pp. 233–237. [Google Scholar]
- 21.Wilson P.W.F., D’Agostino R.B., Levy D., Belanger A.M., Silvers-hartz H., Kannel W.B. Prediction of coronary heart disease using risk factors categories. Circulation. 1998;97:1837–1847. doi: 10.1161/01.cir.97.18.1837. [DOI] [PubMed] [Google Scholar]
- 22.Grundy S.M. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation. 1999;100:988–998. doi: 10.1161/01.cir.100.9.988. [DOI] [PubMed] [Google Scholar]
- 23.Guidelines Subcommittee 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151–183. [PubMed] [Google Scholar]
- 24.British Cardiac Society. British Hyperlipidaemia Association. British Hypertension Society. British Diabetic Association Joint British recommendations on prevention of coronary heart disease in clinical practice. BMJ. 2000;20:705–708. doi: 10.1136/bmj.320.7236.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Thompson W.D., Walter S.D. A reappraisal of the kappa coeficient. J Clin Epidemiol. 1998;41:949–958. doi: 10.1016/0895-4356(88)90031-5. [DOI] [PubMed] [Google Scholar]
- 26.Stern M.P. Glycemia and cardiovascular risk. Diabetes Care. 1997;20:1501. doi: 10.2337/diacare.20.10.1501. [DOI] [PubMed] [Google Scholar]
- 27.Su-Chi L., E-Shyong T., Bee-Yian T., Suok C., Kai F., Chee-Eng T. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care. 2000;23:278–282. doi: 10.2337/diacare.23.3.278. [DOI] [PubMed] [Google Scholar]
- 28.Narejos Pérez S, Espinàs Boquet J, Rodríguez Ferré A, Caballé Moreno E, Alcantarilla Roura D, Barragán Camin B. Utilitat del mètode Framingham per a l'avaluació i l'abordatge terapèutic dels pacients diabètics tipus 2. Butlletí SCMFiC, 18:44–8
- 29.Costa B., Martín F., Donado A., Basora J., Piñol J.L., IGT Research Group IGT vs. IFG (isolated and global). Phenotype and prevalence among high-risk Spanish individuals. Diabetes. 2000;49(Suppl 1):191. [Google Scholar]
- 30.Villar F., Banegas J.R., Rodríguez-Artalejo F., Rey J. Mortalidad cardiovascular en España y sus comunidades autónomas (1975–1992) Med Clin (Barc) 1998;110:321–327. [PubMed] [Google Scholar]
- 31.Wood D., De Backe G., Faegerman O., Graham I., Mancia G., Pyörala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J. 1998;19:1434–1503. doi: 10.1053/euhj.1998.1243. [DOI] [PubMed] [Google Scholar]
- 32.Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y Promoción de la Salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC) Guía de prevención cardiovascular. SERSA; Madrid: 1996. [Google Scholar]
- 33.Villar F., Maiques A., Brotons C., Torcal J., Lorenzo A., Vilaseca J. Recomendaciones preventivas cardiovasculares: aplicaciones prácticas del riesgo cardiovascular. Aten Primaria. 1999;24(Supl 1):66–75. [PubMed] [Google Scholar]